Quarles & Brady 's Simone Colgan Dunlap and Meghan O’Connor offer actionable guidance to help sponsor companies make informed, strategic choices in an evolving AI market.
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
- Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
- How AI Is Rewriting The Future Of TMF And Clinical Quality
- Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address Them
- Penetration Testing In Healthcare: HIPAA And GDPR Requirements
ON-DEMAND WEBINARS
AI, sensors, and evolving regulations are redefining digital health—driving data insights, sensor-based endpoints, and regulatory pathways that shape the future of clinical research.
Edward Bartels, an expert in eCOA solutions, provides an in-depth overview of the market trends, emerging technologies, and how IQVIA eCOA is pioneering advancements in this space.
Join our solutions experts as they demonstrate how Castor ePRO can enhance your clinical trial by improving the patient experience and streamlining site operations.
Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1312761837 data capture]( "How Electronic Source Data Revolutionizes Clinical Research")
How Electronic Source Data Revolutionizes Clinical ResearchBy increasing interoperability and embracing digital solutions, see how the research community can maximize the benefits offered by eSource, leading to improved trial outcomes and data quality.
-
![video conference team meeting-GettyImages-2095813137]( "Streamlined Site Study Start-Up")
Streamlined Site Study Start-UpExplore the critical process of Study Start-Up (SSU) in clinical trials, with an emphasis on the collaborative efforts of sponsors and research sites to enhance efficiency and reduce timelines.
-
![GettyImages-1646106148-AI-pharma-healthcare]( "AI Maturity In Clinical Development")
AI Maturity In Clinical DevelopmentThe future of clinical research relies on operationalizing AI in a scalable, sustainable manner, ensuring that both technological and human factors are harmonized in this transformative journey.
-
![GettyImages-1386486759 EDC]( "Evaluating EDC Systems In A Modern DM Landscape")
Evaluating EDC Systems In A Modern DM LandscapeThis guide provides five crucial recommendations to refine evaluation strategies and choose the right solution for today's complex clinical data environment, optimizing data collection practices.
-
![laboratory scientist laptop GettyImages-1302454417]( "Future Predictions For Clinical Technologies")
Future Predictions For Clinical TechnologiesIn 2025, sponsors are prioritizing configurable, interoperable solutions that integrate seamlessly across IRT, eCOA, CTMS, eConsent, and supply chain systems.
-
![GettyImages-1356381571 world data]( "Why Prospective Real-World Studies Hold Promise For Research")
Why Prospective Real-World Studies Hold Promise For ResearchClinical research has always been a cautious and time-consuming affair. Discover how prospective real-world studies are poised to transform the role of RWE in clinical research.
-
![iStock-1226887050-thought-data-mapping-chart-journey]( "A Beginner's Guide To Compliant Electronic Source Data Capture")
A Beginner's Guide To Compliant Electronic Source Data CaptureWith today’s complex trials, the expectation of gathering faster results in an increasingly decentralized environment is only increasing, imploring investigators to implement electronic source data capture systems. How can researchers ensure this is done correctly? Leveraging the right technology to standardize a compliant process for source data capture is a proven way to reach these goals.
-
![Idea and startup]( "Reducing Risks And Accelerating Study Startup Through An eCOA Library")
Reducing Risks And Accelerating Study Startup Through An eCOA LibraryFind out how the shift towards a more patient-centric drug development landscape has made Clinical Outcome Assessments (COAs) an increasingly necessary and often required tool to gather patient experience data in most trials today.
-
![Mobile Device Management]( "Beyond The Pandemic: Why eCOAs Are Here To Stay")
Beyond The Pandemic: Why eCOAs Are Here To StayThe permanent adoption of eCOA is a natural step in the industry-wide effort to create a more patient-centric clinical trial experience. Learn more in the available blog.
-
![Business Partners Negotiating Deal-GettyImages-1424912318]( "How RFI/RFP Optimization Changes The Game")
How RFI/RFP Optimization Changes The GameSelecting the right vendors can determine whether a clinical trial advances smoothly or stalls under budget overruns and delays.
